Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
![Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies](https://www.ohe.org/wp-content/uploads/2023/01/Cancer_WellcomeCollection_landscape.jpg)
Patient Reported Outcome Measures (PROMs) are used to evaluate health interventions, providing a measure of an individual’s health status. The EQ-5D is a PROM recommended by NICE for measuring health benefits. It considers 5 dimensions of health and can be used across various diseases.